about
Anabolic effects of oxandrolone after severe burnThe effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburnModels of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy.The contribution of muscle to whole-body protein turnover throughout the course of burn injury in children.Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy.Propranolol decreases cardiac work in a dose-dependent manner in severely burned children.Contributions of severe burn and disuse to bone structure and strength in ratsBurn-induced bone loss: importance, mechanisms, and management.Predictors of muscle protein synthesis after severe pediatric burnsNutritional and pharmacological modulation of the metabolic response of severely burned patients: review of the literature (part 1).Effects of pharmacological interventions on muscle protein synthesis and breakdown in recovery from burns.Nutritional deficiencies during critical illness.Nutrition support strategies for severely burned patients.Successful aging: Advancing the science of physical independence in older adults.17β-Estradiol reappropriates mass lost to the hypermetabolic state in thermally injured ratsGlutamine supplementation in critical illness: evidence, recommendations, and implications for clinical practice in burn care.Skeletal muscle is anabolically unresponsive to an amino acid infusion in pediatric burn patients 6 months postinjury.Nutrition and metabolism in the rehabilitative phase of recovery in burn children: a review of clinical and research findings in a speciality pediatric burn hospital.Increased expression of atrogenes and TWEAK family members after severe burn injury in nonburned human skeletal muscle.Modulation of the hypermetabolic response to trauma: temperature, nutrition, and drugsThe hypermetabolic response to burn injury and interventions to modify this responseNutrition in burns: Galveston contributionsInsulin resistance postburn: underlying mechanisms and current therapeutic strategies.Is propranolol of benefit in pediatric burn patients?Randomized controlled trial to determine the efficacy of long-term growth hormone treatment in severely burned children.What, how, and how much should patients with burns be fed?Sarcopenia: Relocating the Forest among the Trees.The influence of sex steroid hormones on the response to trauma and burn injury.Burn Injury Has Skeletal Site-Specific Effects on Bone Integrity and Markers of Bone Remodeling.Dietetic service provision for burn care in the United Kingdom: are nutrition support standards being met?Metabolic and hormonal changes of severely burned children receiving long-term oxandrolone treatment.Audit of successful weight maintenance in adult and paediatric survivors of thermal injury at a UK regional burn centre.Cardiorespiratory Capacity and Strength Remain Attenuated in Children with Severe Burn Injuries at Over 3 Years Postburn.Fifty Years of Burn Care at Shriners Hospitals for Children, Galveston.Bone disease in burn patients.The influence of age and gender on resting energy expenditure in severely burned children.Measures of Total Energy Expenditure and Its Components Using the Doubly Labeled Water Method in Rehabilitating Burn Children.Morphological changes in distant muscle fibers following thermal injury in Wistar rats.The Long-Term Impact of Severe Burn Trauma on Musculoskeletal Health
P2860
Q24541783-2E40AF45-B62F-49DE-8DAB-4F33C62BF34AQ24673024-E1791D68-DB47-418B-ADCA-5BE906DFB915Q33349016-7D108731-65EC-4D41-B20A-693D538F4A4DQ33855401-9D702956-B5AE-48A2-B877-DA3EE6A8A0FBQ34215250-64185D88-F57E-4332-B25E-C647BEABC10CQ34433355-4524D658-9C00-48DB-8EFA-603A44CC4414Q34473003-F32F003A-728D-4CCC-A92A-FDAD0FC43439Q35205493-19D14F14-9EC5-4692-81B1-EEC46C046CDBQ35222745-84CB29D7-A5BD-400F-994A-07E94FA0992DQ35280193-262F5776-80ED-489A-ACC6-7A2FE0619812Q35561653-9593741F-B839-4825-B915-57CD5D585900Q36271082-DE28937A-D431-4DB0-A45F-C5AD38E9806CQ36278386-C8051C09-57CC-491D-9B1E-5A7E75A6A176Q36322590-4287ED04-404C-4178-B09A-6326517775B4Q36492315-352CC844-72AC-49B6-8C2B-A3DCAA61F54EQ36647756-3682F6A9-EECE-4FF2-970F-D8F1BD5C6F4AQ36784199-36B37131-D461-469B-8C37-03BE8E9004D7Q37133591-FE5F1EB8-342C-423B-8E1E-1057F66B821EQ37164742-05DD8788-4852-461D-8589-73BD51F6F6DCQ37178361-BAE14F26-C727-442B-BCC0-185A13CFD05AQ37181299-CB7C4E2E-DCC3-4C39-815D-50D3B5FDA758Q37186721-EB39F322-28E5-4D19-ABE9-6A97A79CB1DAQ37241722-A0A79047-11E4-4618-AAB6-F5007E9E3BBCQ37640359-9CDF432A-CD45-4B6D-9750-C9FCF2583528Q37674052-99986CD9-395A-46F4-99B7-393363E746CFQ37881472-3CBB3915-5D1D-4C38-AC39-87875791C05DQ38645615-7FF9E9AE-9C80-4D91-9CCB-E40CA8A7A4B0Q41109551-4C23A995-FFF6-46E4-9681-DD024915F3D6Q42738566-F89E58C4-406E-4583-A236-D60A51CE6D10Q44217497-24EF8C52-F62C-456B-8615-2B93E92ACD5DQ46681488-42F3E7D3-6007-4584-BCE9-A802CD8862DAQ47407617-A6AA4990-A530-4162-9A64-9300C43C15CDQ47779074-79BEDBC5-C768-4E31-AFC1-F68D81F06C81Q49814788-D5FB1040-2218-4B1E-A525-A259D16F3AC2Q51061171-C3521396-D029-4CD9-9F4A-CEF2AD311B5CQ51798733-502B2317-52C5-45BF-AAB9-CB43CFB01DB7Q51820100-BA58C4C4-4BD8-48CD-85A9-9273161202AAQ53286260-DEDCFC80-AC2D-462C-8C47-9A48E3417471Q57797690-7CAD0A9A-9CDA-42E6-B28E-4326B0136A5D
P2860
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Growth delay in postburn pediatric patients.
@en
Growth delay in postburn pediatric patients.
@nl
type
label
Growth delay in postburn pediatric patients.
@en
Growth delay in postburn pediatric patients.
@nl
prefLabel
Growth delay in postburn pediatric patients.
@en
Growth delay in postburn pediatric patients.
@nl
P1433
P1476
Growth delay in postburn pediatric patients.
@en
P2093
P304
P356
10.1001/ARCHSURG.1990.01410150114021
P577
1990-03-01T00:00:00Z